A carregar...
Glycoprotein IIb/IIIa inhibitors and low‐molecular‐weight heparins: A combined role in coronary interventions?
Management strategies for acute coronary syndromes (ACS) are making increasing use of both low‐molecular‐weight heparins (LMWHs) and glycoprotein (GP) IIb/IIIa inhibitors. To date, however, relatively few studies have assessed the clinical potential of these two classes of agents in combination. The...
Na minha lista:
| Publicado no: | Clin Cardiol |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley Periodicals, Inc.
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6654834/ https://ncbi.nlm.nih.gov/pubmed/11286313 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960241304 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|